Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories

ArXi:2605.30275v1 Announce Type: new Earlier detection of pancreatic cancer is key to enabling wider access to curative treatment and reducing cancer deaths; however, screening is presently not viable. Latent indicators of pathology are evident in an individual's disease and blood test trajectories and may predict the development of pancreatic cancer.